Modified protein kinase A-specific oligonucleotides and methods of their use


Ontology type: sgo:Patent     


Patent Info

DATE

2006-07-11T00:00

AUTHORS

AGRAWAL SUDHIR

ABSTRACT

Disclosed are synthetic, modified oligonucleotides complementary to, and capable of down-regulating the expression of, nucleic acid encoding protein kinase A subunit RIα. The modified oligonucleotides have from about 15 to about 30 nucleotides and are hybrid, inverted hybrid, or inverted chimeric oligonucleotides. Also disclosed are therapeutic compositions containing such oligonucleotides and methods of using the same. In addition, therapeutic compositions and methods of their use are described which are directed to a synergistic effect resulting from the combination of oligonucleotides of the invention and other therapeutic compositions and methods. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "AGRAWAL SUDHIR", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01674433", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004877232", 
          "https://doi.org/10.1007/bf01674433"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0696-668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039646445", 
          "https://doi.org/10.1038/nm0696-668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-199528010-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047632676", 
          "https://doi.org/10.2165/00003088-199528010-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt0697-537", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022203075", 
          "https://doi.org/10.1038/nbt0697-537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/374546a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034049921", 
          "https://doi.org/10.1038/374546a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0297-231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003429757", 
          "https://doi.org/10.1038/nm0297-231"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-07-11T00:00", 
    "description": "

Disclosed are synthetic, modified oligonucleotides complementary to, and capable of down-regulating the expression of, nucleic acid encoding protein kinase A subunit RIα. The modified oligonucleotides have from about 15 to about 30 nucleotides and are hybrid, inverted hybrid, or inverted chimeric oligonucleotides. Also disclosed are therapeutic compositions containing such oligonucleotides and methods of using the same. In addition, therapeutic compositions and methods of their use are described which are directed to a synergistic effect resulting from the combination of oligonucleotides of the invention and other therapeutic compositions and methods.

", "endDate": "2015-08-17", "id": "sg:patent.US-7074768-B2", "name": "Modified protein kinase A-specific oligonucleotides and methods of their use", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.452508.e", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7074768-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-09-02T16:21", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/patent/patent_42.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7074768-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7074768-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7074768-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7074768-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

50 TRIPLES      15 PREDICATES      22 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7074768-B2 schema:about anzsrc-for:06
2 anzsrc-for:0601
3 schema:author N0b3edfbf8a3c4ff687eabd26f051725f
4 schema:citation sg:pub.10.1007/bf01674433
5 sg:pub.10.1038/374546a0
6 sg:pub.10.1038/nbt0697-537
7 sg:pub.10.1038/nm0297-231
8 sg:pub.10.1038/nm0696-668
9 sg:pub.10.2165/00003088-199528010-00002
10 schema:datePublished 2006-07-11T00:00
11 schema:description <p num="p-0001">Disclosed are synthetic, modified oligonucleotides complementary to, and capable of down-regulating the expression of, nucleic acid encoding protein kinase A subunit RI<sub>&#945;</sub>. The modified oligonucleotides have from about 15 to about 30 nucleotides and are hybrid, inverted hybrid, or inverted chimeric oligonucleotides. Also disclosed are therapeutic compositions containing such oligonucleotides and methods of using the same. In addition, therapeutic compositions and methods of their use are described which are directed to a synergistic effect resulting from the combination of oligonucleotides of the invention and other therapeutic compositions and methods.</p>
12 schema:endDate 2015-08-17
13 schema:name Modified protein kinase A-specific oligonucleotides and methods of their use
14 schema:recipient grid-institutes:grid.452508.e
15 schema:sameAs https://app.dimensions.ai/details/patent/US-7074768-B2
16 schema:sdDatePublished 2022-09-02T16:21
17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
18 schema:sdPublisher N963ccc6dd8504d74990599e6b47a3d62
19 sgo:license sg:explorer/license/
20 sgo:sdDataset patents
21 rdf:type sgo:Patent
22 N0b3edfbf8a3c4ff687eabd26f051725f rdf:first N641e04e39c7a4c898569bdb99993c735
23 rdf:rest rdf:nil
24 N641e04e39c7a4c898569bdb99993c735 schema:name AGRAWAL SUDHIR
25 rdf:type schema:Person
26 N963ccc6dd8504d74990599e6b47a3d62 schema:name Springer Nature - SN SciGraph project
27 rdf:type schema:Organization
28 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
29 rdf:type schema:DefinedTerm
30 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
31 rdf:type schema:DefinedTerm
32 sg:pub.10.1007/bf01674433 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004877232
33 https://doi.org/10.1007/bf01674433
34 rdf:type schema:CreativeWork
35 sg:pub.10.1038/374546a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034049921
36 https://doi.org/10.1038/374546a0
37 rdf:type schema:CreativeWork
38 sg:pub.10.1038/nbt0697-537 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022203075
39 https://doi.org/10.1038/nbt0697-537
40 rdf:type schema:CreativeWork
41 sg:pub.10.1038/nm0297-231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003429757
42 https://doi.org/10.1038/nm0297-231
43 rdf:type schema:CreativeWork
44 sg:pub.10.1038/nm0696-668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039646445
45 https://doi.org/10.1038/nm0696-668
46 rdf:type schema:CreativeWork
47 sg:pub.10.2165/00003088-199528010-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047632676
48 https://doi.org/10.2165/00003088-199528010-00002
49 rdf:type schema:CreativeWork
50 grid-institutes:grid.452508.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...